Treatment

Revision as of 21:46, 11 July 2020 by Sahar Memar Montazerin (talk | contribs) (Protected "Treatment" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
Jump to navigation Jump to search


To go back to the main page, click here.

Short QT syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Type 1
Type 2
Type 3
Type 4
Type 5

Pathophysiology

Causes

Triggers

Differentiating Short QT syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EP studies

Genetic Testing

Treatment

AICD Placement

Medical Therapy

Case Studies

Case #1

Treatment On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Treatment

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Treatment

CDC on Treatment

Treatment in the news

Blogs on Treatment

Directions to Hospitals Treating Short QT syndrome

Risk calculators and risk factors for Treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Sumanth Khadke, MD[2], Ogechukwu Hannah Nnabude, MD


Overview

Compliance with avoidance is important. The key to avoidance is proper evaluation and detection of causative allergen. Wear appropriate clothing to protect against irritants at home and in a work environment. [1] [2]


Treatment

High-potency topical corticosteroids, e.g. clobetasol propionate 0.05% cream, may be used to reduce the inflammation. [3] As a general rule, high-potency corticosteroids should not be used on thin skin, e.g. face, genitals, intertriginous areas, to avoid the risk of skin atrophy. Antihistamines such as hydroxyzine and cetirizine are recommended to control pruritus. Systemic steroids are advised in severe cases but should be tapered gradually to prevent recurrences. Friction should be avoided as well as the use of soaps, perfumes, and dyes. Emollients are used for hydrating the skin. Tacrolimus ointment and pimecrolimus cream are immunomodulating drugs that inhibit calcineurin and are helpful in allergic contact dermatitis.



Reference

  1. Soltanipoor M, Kezic S, Sluiter JK, de Wit F, Bosma AL, van Asperen R; et al. (2019). "Effectiveness of a skin care programme for the prevention of contact dermatitis in healthcare workers (the Healthy Hands Project): A single-centre, cluster randomized controlled trial". Contact Dermatitis. 80 (6): 365–373. doi:10.1111/cod.13214. PMC 6593800 Check |pmc= value (help). PMID 30652317.
  2. Nedorost S (2018). "A diagnostic checklist for generalized dermatitis". Clin Cosmet Investig Dermatol. 11: 545–549. doi:10.2147/CCID.S185357. PMC 6217130. PMID 30464569.
  3. Vernon HJ, Olsen EA (1990). "A controlled trial of clobetasol propionate ointment 0.05% in the treatment of experimentally induced Rhus dermatitis". J Am Acad Dermatol. 23 (5 Pt 1): 829–32. doi:10.1016/0190-9622(90)70297-u. PMID 2147698.